Company Now Is In Two High Growth Rate Global Markets With iSTRYM In The DTx Market, Projected To Reach $56 Billion By 2025 And The Global Psychedelic Market Projected To Reach Over $7.5 Billion By...
Psychedelic
Numinus Wellness: A rising star in the Psychedelic Investing space!
NUMINUS WELLNESS INC. (TSX-V:NUMI) Numinus Wellness Inc. is a Canadian stock taking the psychedelic industry by storm. It’s already been granted a licence by Health Canada to cultivate, extract, and...
Early Facebook investor getting set to make another IPO killing with compassion!
Compass Pathways (Nasdaq:CMPS), a revolutionary scientific emerging growth company, is about to launch its initial public offering (IPO) on the Nasdaq stock exchange. It has the full endorsement and...
The compelling investment case for GreenStar Biosciences (CSE:GSTR | OTC:GTSIF)
Entering a second market can often lead to a positive step-change in performance for a well-run growth company. It diversifies risk and presents the market with an alternative stream of news flow....
Eleusian acquisition & three provisional patents propel GreenStar Biosciences into the exciting world of Transformational Medicine – (CSE:GSTR | OTC:GTSIF)
Mild traumatic brain injury (MTBI) – better known as concussion – is notoriously difficult to treat. It affects as many as 2 million Americans each year. While many patients tend to recover,...